| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.047 | 0.6 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |